A randomised phase III study of 72 hour infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3)
- J. Shamash (Lead / Corresponding author)
- , S. J. Sarker
- , R. Huddart
- , S. Harland
- , J. K. Joffe
- , D. Mazhar
- , A. Birtle
- , J. White
- , K. Chowdhury
- , P. Wilson
- , M. R. Marshall
- , S. Vinnicombe
Research output: Contribution to journal › Article › peer-review
21
Link opens in a new tab
Citations
(Scopus)
271
Downloads
(Pure)